Strontium-89 (Metastron)

General information

Radioactive strontium

Diseases for which it was used

• Prostate cancer

History of changes in FDA indication

• 1993-06-18: Initial approval for the relief of bone pain in patients with painful skeletal metastases.

History of changes in PMDA indication

• 2007-07-31: Initial approval for pain relief in bone scintigraphy-positive metastatic lesions in patients with solid cancers.

Also known as

• Brand name: Metastron